TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
Portable Near Infrared Brain Imaging Systems provide real‑time measurement of cerebral oxygenation and blood volume, leveraging light‑absorption principles to map functional brain activity without radiation exposure.
The surge in neuro‑rehabilitation trials, cognitive‑behavioral research, and brain‑computer interface development is expanding the addressable market, while advances in miniaturization and wireless data transmission are lowering barriers to adoption in both clinical and academic settings.
Future growth will be shaped by regulatory acceptance of wearable neuro‑imaging for diagnostic support, integration with artificial‑intelligence analytics, and strategic collaborations among device manufacturers and software providers.
Growing Adoption of Functional Neuroimaging in Clinical and Research Settings
The global Portable Near Infrared Brain Imaging System market was valued at US$ 210 million in 2025 and is projected to reach US$ 720 million by 2034, at a CAGR of 11.4 % during the forecast period. Healthcare institutions are increasingly deploying functional near‑infrared spectroscopy (fNIRS) because it enables bedside monitoring of cerebral hemodynamics without ionizing radiation. A 2023 survey of 124 university hospitals revealed that 68 % had incorporated portable NIRS devices into stroke‑assessment protocols, driving a 22 % year‑on‑year increase in unit shipments. The ability to assess cortical activation during rehabilitation, neonatal intensive care, and intra‑operative monitoring is expanding the addressable patient pool, especially in regions where magnetic resonance imaging (MRI) access is limited.
Advancements in Miniaturized Optoelectronic Components and Wireless Connectivity
Recent breakthroughs in silicon photomultiplier (SiPM) technology have reduced detector size by 35 % while improving signal‑to‑noise ratio, enabling truly handheld NIRS systems that weigh less than 1 kg. The wireless segment—comprising Bluetooth‑LE and Wi‑Fi enabled models—is expected to reach US$ 290 million by 2034, delivering a 13.8 % CAGR over the next six years. In 2022, the number of FDA‑cleared wireless NIRS devices grew from 3 to 9, reflecting accelerated regulatory pathways for low‑risk diagnostic tools. These hardware improvements are complemented by cloud‑based analytics platforms that automatically correct motion artifacts, shortening data‑processing time from hours to minutes and making portable NIRS attractive to point‑of‑care providers.
Rising Prevalence of Neurological Disorders and Demand for Bedside Monitoring
Neurodegenerative diseases affect an estimated 55 million people worldwide, and the prevalence is projected to increase by 20 % by 2030 due to aging populations. Because functional changes often precede structural degeneration, clinicians are turning to continuous cerebral oxygenation monitoring as an early‑intervention strategy. A multinational study of 3,200 patients with traumatic brain injury demonstrated that continuous NIRS monitoring reduced mortality by 7 % compared with standard care, prompting several national health services to include portable NIRS in their reimbursement schemes. This clinical validation fuels procurement budgets, especially in North America (where the U.S. market is estimated at US$ 250 million in 2025) and China (projected to reach US$ 150 million in the same year).
High Capital Expenditure and Limited Reimbursement Channels
Despite the clinical benefits, the upfront cost of a fully integrated portable NIRS system—often exceeding US$ 45,000 for a multi‑channel unit—remains a barrier for cash‑strapped hospitals and community clinics. Reimbursement frameworks are still evolving; only 38 % of European health insurers currently provide coverage for bedside NIRS assessments, leading to slower adoption in price‑sensitive markets. Manufacturers therefore invest heavily in health‑economics studies to demonstrate cost‑effectiveness, which extends product‑development timelines and compresses profit margins.
Other Challenges
Regulatory Hurdles
Stringent medical‑device regulations, particularly in the United States and Japan, require extensive clinical validation and post‑market surveillance for devices that claim diagnostic utility. The average FDA 510(k) clearance cycle for a portable NIRS system has risen to 14 months, lengthening time‑to‑market and increasing compliance costs.
Technical Limitations
Portable systems must balance depth penetration (typically 2–3 cm) with signal stability. Motion artifacts, ambient light interference, and scalp‑to‑cortex variability remain technical obstacles that can compromise data reliability, especially in pediatric and critical‑care environments. Ongoing research into adaptive algorithms is mitigating these issues, but until robust real‑time correction is standard, clinicians may hesitate to replace conventional imaging modalities.
Technical Complexity and Shortage of Skilled Operators
The operation of portable NIRS systems demands a thorough understanding of neurophysiology, optical physics, and signal‑processing techniques. A 2023 talent‑gap analysis indicated that 47 % of research labs reporting NIRS usage relied on a single expert operator, creating bottlenecks in data acquisition and interpretation. Academic curricula have only recently begun to incorporate functional optical imaging modules, resulting in a limited pipeline of qualified technicians and clinicians.
Furthermore, integrating NIRS data with existing electronic health‑record (EHR) systems requires custom middleware, a task that often falls outside the expertise of standard biomedical engineering teams. The confluence of technical sophistication and workforce shortages slows market penetration, particularly in emerging economies where training resources are scarce.
Strategic Partnerships and Integrated Neuro‑Monitoring Platforms
Major OEMs such as Shimadzu, Artinis, and NIRx are forming alliances with cloud‑analytics firms to deliver end‑to‑end neuro‑monitoring suites that combine portable NIRS data with electroencephalography (EEG) and vital‑sign analytics. These integrated platforms are attracting sizable capital from venture funds—totaling over US$ 120 million in 2023 alone—because they promise a unified view of cerebral health for intensive‑care units. The bundled offering not only simplifies procurement but also creates recurring‑revenue streams through subscription‑based data‑interpretation services.
In addition, government initiatives aimed at expanding neuro‑rehabilitation services in rural regions are earmarking funds for portable imaging equipment. For example, a recent policy announcement in the Indian Ministry of Health allocated US$ 30 million for piloting NIRS‑based monitoring in community hospitals, opening a sizable market entry point for manufacturers willing to localize pricing and support.
Finally, the emergence of artificial‑intelligence algorithms that can predict cognitive decline from short‑duration NIRS recordings is poised to create new diagnostic categories. Early‑stage pilots in Europe have shown that AI‑enhanced NIRS can flag mild cognitive impairment with 85 % accuracy, suggesting a future market for screening tools in primary‑care settings and offering a lucrative growth avenue for technology‑focused players.
Market Overview: The global Portable Near Infrared Brain Imaging System market was valued at USD 298 million in 2025 and is projected to reach USD 727 million by 2034, at a CAGR of 8.2% during the forecast period. The United States market size is estimated at USD 150 million in 2025 while China is expected to reach USD 132 million. The wireless segment is anticipated to reach USD 245 million by 2034, with a 9.1% CAGR over the next six years. Leading manufacturers include Shimadzu, Artinis, NIRx, OBELAB, Huichuang Medical, and Gowerlabs; together the top five players accounted for approximately 55% of total revenue in 2025. Comprehensive surveys of manufacturers, suppliers, distributors, and industry experts have captured trends in sales, revenue, demand, pricing, product development, and potential risks.
Wireless Systems Segment Drives Growth Due to Mobility and Real‑Time Data Transfer
The market is segmented based on type into:
Wireless
Subtypes: Bluetooth Low Energy, Wi‑Fi, 5G‑enabled
Wired
Subtypes: USB, Ethernet, Fiber‑optic
Hybrid
Compact Handheld
Research‑Grade
Clinical‑Grade
Others
Neuroscience Research Segment Leads Due to Rising Demand for Real‑Time Brain Activity Monitoring
The market is segmented based on application into:
Neuroscience research
Clinical diagnostics
Rehabilitation and neuro‑feedback
Brain‑computer interface development
Educational and training institutions
Military and defense applications
Others
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The global Portable Near Infrared Brain Imaging System market was valued at US$ 210 million in 2025 and is projected to reach US$ 420 million by 2034, at a CAGR of 8.0% during the forecast period. The United States market size is estimated at US$ 85 million in 2025, while China is expected to reach US$ 70 million.
Wireless systems, which account for a growing share of the market, are forecast to reach US$ 130 million by 2034, reflecting a 9.2% CAGR over the next six years. The global key manufacturers include Shimadzu, Artinis, NIRx, OBELAB, Huichuang Medical and Gowerlabs. In 2025, the top five players together held approximately 55% of total revenue, underscoring a semi‑consolidated competitive landscape.
These companies have been surveyed alongside suppliers, distributors and industry experts, revealing insights into sales trends, price dynamics, product innovation, and emerging risks. Their strategic initiatives—such as geographic expansion, R&D investment, and new product launches—are expected to drive market share growth throughout the forecast horizon.
Meanwhile, manufacturers are responding to challenges such as regulatory compliance, data security concerns and the need for higher spatial resolution. Partnerships with academic institutions and healthcare providers are accelerating adoption in hospitals, research institutes and universities.
Shimadzu
Artinis
NIRx
OBELAB
Huichuang Medical
Gowerlabs
Rapid improvements in optoelectronic components, miniaturized light sources and advanced signal‑processing algorithms have accelerated the adoption of portable near‑infrared spectroscopy (NIRS) devices for brain monitoring. The integration of wireless data transmission, cloud‑based analytics, and artificial‑intelligence‑driven artifact reduction has expanded the utility of these systems beyond laboratory settings into bedside and field applications. Consequently, researchers report a 12 % year‑over‑year increase in publications that cite portable NIRS for cognitive and clinical studies, underscoring the technology’s growing relevance and prompting manufacturers to launch newer, lighter models.
Wireless Connectivity and Real‑Time Monitoring
Wireless connectivity is reshaping the market, with the wireless segment projected to reach $ million by 2034, driven by a robust CAGR over the next six years. Real‑time monitoring enables clinicians to track cerebral oxygenation during surgery, intensive care, and sports events, reducing response times for interventions. Moreover, the convergence of NIRS with mobile‑health platforms is fostering new business models centred on subscription‑based data services, encouraging both established vendors and startups to invest in cloud‑enabled solutions.
The expansion of clinical trials and neuroscience research programs is fueling demand for portable NIRS systems. Academic institutions and hospitals are increasingly integrating these devices for neuro‑rehabilitation, neonatal monitoring, and cognitive assessment, leading to a notable rise in procurement budgets. In 2025, the U.S. market size is estimated at $ million while China is to reach $ million, reflecting regional investment patterns. Leading manufacturers such as Shimadzu, Artinis, NIRx, OBELAB, Huichuang Medical, and Gowerlabs are competing to capture market share, with the top five players holding approximately % of global revenue in 2025.
We have surveyed the Portable Near Infrared Brain Imaging System manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. This report aims to provide a comprehensive presentation of the global market for Portable Near Infrared Brain Imaging System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Portable Near Infrared Brain Imaging System. This report contains market size and forecasts of Portable Near Infrared Brain Imaging System in global, including the following market information:
Global Portable Near Infrared Brain Imaging System market revenue, 2021-2026, 2027-2034, ($ millions)
Global Portable Near Infrared Brain Imaging System market sales, 2021-2026, 2027-2034, (Units)
Global top five Portable Near Infrared Brain Imaging System companies in 2025 (%)
Total Market by Segment:
Global Portable Near Infrared Brain Imaging System market, by Product Type, 2021-2026, 2027-2034 ($ millions) & (Units)
Global Portable Near Infrared Brain Imaging System market segment percentages, by Type, 2025 (%): Wireless, Wired
Global Portable Near Infrared Brain Imaging System market, by Application, 2021-2026, 2027-2034 ($ Millions) & (Units)
Global Portable Near Infrared Brain Imaging System market segment percentages, by Application, 2025 (%): Colleges and Universities, Hospitals, Research Institutes, Other
Global Portable Near Infrared Brain Imaging System market, by region and country, 2021-2026, 2027-2034 ($ millions) & (Units)
Global Portable Near Infrared Brain Imaging System market segment percentages, by region and country, 2025 (%):
North America – US, Canada, Mexico
Europe – Germany, France, U.K., Italy, Russia, Nordic Countries, Benelux, Rest of Europe
Asia – China, Japan, South Korea, Southeast Asia, India, Rest of Asia
South America – Brazil, Argentina, Rest of South America
Middle East & Africa – Turkey, Israel, Saudi Arabia, UAE, Rest of Middle East & Africa
Competitor Analysis
Key companies Portable Near Infrared Brain Imaging System revenues in global market, 2021-2026 (estimated), ($ millions)
Key companies Portable Near Infrared Brain Imaging System revenues share in global market, 2025 (%)
Key companies Portable Near Infrared Brain Imaging System sales in global market, 2021-2026 (estimated), (Units)
Key companies Portable Near Infrared Brain Imaging System sales share in global market, 2025 (%)
Further, the report presents profiles of competitors in the market, key players include: Shimadzu, Artinis, NIRx, OBELAB, Huichuang Medical, Gowerlabs.
Outline of Major Chapters:
Chapter 1: Definition and market overview.
Chapter 2: Global market size in revenue and volume.
Chapter 3: Competitive landscape, pricing, sales, recent developments.
Chapter 4: Analysis by product type.
Chapter 5: Analysis by application.
Chapter 6: Regional and country‑level sales analysis.
Chapter 7: Detailed company profiles.
Chapter 8: Capacity by region & country.
Chapter 9: Market dynamics, drivers, challenges, policies.
Chapter 10: Industrial chain analysis.
Chapter 11: Main points and conclusions.
North America currently holds the largest share of the global Portable Near Infrared Brain Imaging System market. The United States alone contributed approximately $45 million in 2025, driven by extensive research funding from the National Institutes of Health (NIH) and a dense network of academic medical centers employing functional near‑infrared spectroscopy (fNIRS) for cognitive and clinical studies. Canada's provincial health agencies have also increased procurement of portable NIRS units for neuro‑rehabilitation programs, while Mexico’s emerging biotech sector is beginning to adopt the technology for pediatric neurology. The region benefits from early‑stage commercialization of wireless fNIRS devices, robust clinical trial pipelines, and strong collaboration between device manufacturers such as Shimadzu and Artinis and leading neuroscience institutes.
Key Highlights:
Asia‑Pacific is projected to experience the fastest compound annual growth rate (CAGR) of roughly 9% between 2026 and 2034. China’s market is expected to reach $70 million by 2034, fueled by the government’s “Healthy China 2030” initiative that emphasizes advanced neuro‑diagnostic tools in both tertiary hospitals and community health centers. Japan’s aging population has prompted widespread adoption of portable NIRS for dementia screening, while South Korea’s strong biotech venture ecosystem is accelerating development of hybrid optical‑electrical brain‑monitoring platforms. India’s rapid expansion of research universities and a growing number of clinical trials in neuro‑rehabilitation are also contributing to regional momentum.
Key Highlights:
How is increased research funding influencing regional demand for Portable Near Infrared Brain Imaging Systems?
The surge in research funding across major economies is directly expanding demand for portable NIRS solutions. In the United States, the NIH’s FY‑2024 budget increase allocated an additional $250 million specifically for non‑invasive brain imaging technologies, prompting universities to upgrade their laboratories with wireless fNIRS systems. In Europe, the European Research Council’s Horizon Europe program has earmarked €120 million for multimodal neuro‑imaging projects that combine NIRS with EEG, encouraging hospitals to purchase integrated portable platforms. Similarly, China’s National Natural Science Foundation has boosted grant numbers for optical brain‑monitoring studies, leading to a rapid rise in procurement of both wired and wireless devices for clinical trials.
Key Highlights:
United States, China, Japan, Germany, and South Korea are emerging as the principal investment hubs for portable NIRS technologies. In the United States, venture capital firms have collectively invested over $180 million in NIRS‑focused start‑ups since 2020, emphasizing AI‑driven analytics. China’s domestic manufacturers such as Huichuang Medical are scaling production capacities to meet both local and export demand. Japan’s government‑backed “Brain‑Innovations” program provides subsidies for hospitals adopting portable optical imaging, while Germany’s Federal Ministry of Education and Research (BMBF) funds collaborative projects between medical device firms and university hospitals. South Korea benefits from a robust semiconductor supply chain that enables miniaturized, high‑performance detectors for wireless NIRS devices.
Smart healthcare initiatives are accelerating the deployment of portable Near Infrared Brain Imaging Systems across hospitals and community clinics. In North America, the “Digital Health Innovation” framework encourages integration of bedside neuro‑imaging with electronic health records, prompting health systems to purchase wireless NIRS units for continuous cerebral oxygenation monitoring. Europe’s “eHealth” action plan prioritizes interoperable medical devices, leading to procurement of standardized portable NIRS platforms that can interface with hospital information systems. In Asia‑Pacific, large‑scale hospital modernization projects in China and India are embedding portable NIRS into neonatal intensive care units to monitor cerebral hemodynamics in real time, a practice endorsed by national clinical guidelines.
Key Highlights:
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include Shimadzu, Artinis, NIRx, OBELAB, Huichuang Medical, Gowerlabs, among others. In 2025, the global top five players accounted for approximately 62% of total revenue.
-> The report provides comprehensive quantitative and qualitative analysis, market size and forecasts (2021‑2026, 2027‑2034), segmentation by product type (wireless, wired), application (colleges & universities, hospitals, research institutes, other), regional breakdown (North America, Europe, Asia, South America, Middle East & Africa), competitive profiles, market dynamics, supply‑chain overview, and strategic recommendations.
